{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:01:30Z","timestamp":1779364890049,"version":"3.53.0"},"reference-count":120,"publisher":"Wiley","issue":"7-8","license":[{"start":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T00:00:00Z","timestamp":1222041600000},"content-version":"vor","delay-in-days":83,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>The inability of tumour\u2010initiating cancer stem cells (CSCs) to bring about a net increase in tumour mass could be described as a source of tumour dormancy. While CSCs may be intrinsically capable of driving malignant growth, to do so they require compatible surroundings of supportive cells, growth factors, adhesion molecules and energy sources (e.g. glucose and oxygen), all of which constitute what may be referred to as a \u2018permissive' CSC niche. However, in some circumstances, the configuration of these factors could be incompatible with CSC growth (a \u2018non\u2010permissive' niche) and lead to their death or dormancy. CSCs and their niches may also differ between adult and paediatric cancers. In this regard the various facets of the tumour\u2010vascular interface could serve as elements of the CSC niche. Indeed, transformed cells with an increased tumour\u2010initiating capability may preferentially reside in specific zones adjacent to tumour blood vessels, or alternatively originate from poorly perfused and hypoxic areas, to which they have adapted. CSCs themselves may produce increased amounts of angiogenic factors, or rely for this on their progeny or activated host stromal cells. It is likely that \u2018vascular' properties of tumour\u2010initiating cells and those of their niches may diversify and evolve with tumour progression. The emerging themes in this area include the role of vascular (and bone marrow) aging, vascular and metabolic comorbidities (e.g. atherosclerosis) and the effects of the coagulation system (both at the local and systemic levels), all of which could impact the functionality of CSCs and their niches and affect tumour growth, dormancy and formation of occult as well as overt metastases. In this article we will discuss some of the vascular properties of CSCs relevant to tumour dormancy and progression, including: (i) the role of CSCs in regulating tumour vascular supply, i.e the onset and maintenance of tumour angiogenesis; (ii) the consequences of changing vascular demand (vascular dependence) of CSC and their progeny; (iii) the interplay between CSCs and the vascular system during the process of metastasis, and especially (iv) the impact of the coagulation system on the properties of CSC and their niches. We will use the oncogene\u2010driven expression of tissue factor (TF) in cancer cells as a paradigm in this regard, as TF represents a common denominator of several vascular processes that commonly occur in cancer, most notably coagulation and angiogenesis. In so doing we will explore the therapeutic implications of targeting TF and the coagulation system to modulate the dynamics of tumour growth and tumour dormancy.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2008.01058.x","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T09:37:47Z","timestamp":1222076267000},"page":"660-676","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Vascular determinants of cancer stem cell dormancy\u2014do age and coagulation system play a role?"],"prefix":"10.1111","volume":"116","author":[{"given":"JANUSZ","family":"RAK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHLOE","family":"MILSOM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOANNE","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,22]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00046903"},{"key":"e_1_2_11_3_2","first-page":"4909","article-title":"Perspectives on clonogenic tumor cells, stem cells, and oncogenes","volume":"44","author":"Buick RN","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/35102167"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2002.18514.x"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.3233\/BD-2007-26108"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm136"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.09.004"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02766.x"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05372"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03128"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2256"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.5.16.2995"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304293281706"},{"key":"e_1_2_11_15_2","first-page":"161","volume-title":"Cancer Medicine","author":"Folkman J","year":"2003"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1803"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj068"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0295-149"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.3.861"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90200-3"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00396-6"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-3946fje"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.14.7.871"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00369-1"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.17.1303"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070298"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04957"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04186"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(07)70135-4"},{"key":"e_1_2_11_30_2","first-page":"1739","article-title":"Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous inoculation","volume":"38","author":"Auerbach R","year":"1978","journal-title":"Cancer Res"},{"key":"e_1_2_11_31_2","first-page":"379","article-title":"Transplantable mouse 16\/c adenocarcinoma as a model in experimental cancer therapy. I. Modifications of tumor \u2010host interactions by therapeutic procedures","volume":"37","author":"Rak J","year":"1989","journal-title":"Arch Immunol Ther Exp"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.2307\/3577551"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00046341"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio242148a0"},{"key":"e_1_2_11_35_2","first-page":"776","article-title":"Variant sublines of early\u2010stage human melanomas selected for tumorigenicity in nude mice express a multicytokine resistant phenotype","volume":"144","author":"Kobayashi H","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_11_36_2","first-page":"3075","article-title":"Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype","volume":"56","author":"Bani MR","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009275307663"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/1781391a0"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800740326"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2007.05.037"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32801080fe"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.21.9857"},{"key":"e_1_2_11_43_2","first-page":"15F","article-title":"A new quantitative method for assessing angiogenesis and anti\u2010angiogenic agents using reconstituted basement membrane, heparin and FGF [abstract]","author":"Passaniti A","year":"1991","journal-title":"J Cell Biochem"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116166"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2000.00012.x"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.11.2268"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1971"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/269804a0"},{"key":"e_1_2_11_49_2","first-page":"6083","article-title":"Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia\u2010induced vascular endothelial growth factor up\u2010regulation and protein expression","volume":"54","author":"Hlatky L","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1479"},{"key":"e_1_2_11_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910590209"},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00030-8"},{"key":"e_1_2_11_53_2","first-page":"490","article-title":"Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up\u2010regulation in ras\u2010transformed epithelial cells and fibroblasts","volume":"60","author":"Rak J","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1010"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.020"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-6-541"},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1675"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04957"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64083-7"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.2.146"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2003.09.014"},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/89997"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/379088a0"},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7521539"},{"key":"e_1_2_11_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00437476"},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068327"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji174"},{"key":"e_1_2_11_68_2","first-page":"654","volume-title":"Phlegmasia alba dolens. Clinique Medicale de l'Hotel\u2010Dieu de Paris. The Sydenham Society","author":"Trousseau A","year":"1865"},{"key":"e_1_2_11_69_2","first-page":"851","volume-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","author":"Dvorak FH","year":"2006"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.3_suppl.58S"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0296-209"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0247com"},{"key":"e_1_2_11_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000183884.06371.52"},{"key":"e_1_2_11_74_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0037-1616231","article-title":"Tissue factor\u2013a receptor involved in the control of cellular properties, including angiogenesis","volume":"86","author":"Chen J","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616202"},{"key":"e_1_2_11_76_2","first-page":"3","volume-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","author":"Colman RW","year":"1994"},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616227"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.002"},{"key":"e_1_2_11_79_2","first-page":"217","article-title":"Anticoagulants as cancer therapy","volume":"17","author":"Zacharski LR","year":"1990","journal-title":"Semin Oncol"},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000171155.05809.bf"},{"key":"e_1_2_11_81_2","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","article-title":"Fibrinogen is animportant determinant of the metastatic po\u2010tential of circulating tumor cells","volume":"96","author":"Palumbo JS","year":"2000","journal-title":"Blood"},{"key":"e_1_2_11_82_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933337"},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1037"},{"key":"e_1_2_11_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/383073a0"},{"key":"e_1_2_11_85_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.13.6258"},{"key":"e_1_2_11_86_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.5.1583.1583"},{"key":"e_1_2_11_87_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-2042"},{"key":"e_1_2_11_88_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933341"},{"key":"e_1_2_11_89_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pai.0000213157.94804.fc","article-title":"Expression of tissue factor in prostate cancer correlates with malignant phenotype","volume":"16","author":"Kaushal V","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"e_1_2_11_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10061"},{"key":"e_1_2_11_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<295::AID-CNCR8>3.0.CO;2-U"},{"key":"e_1_2_11_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91690-3"},{"key":"e_1_2_11_93_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3376"},{"key":"e_1_2_11_94_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026516920119"},{"key":"e_1_2_11_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00972.x"},{"key":"e_1_2_11_96_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2350"},{"key":"e_1_2_11_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00787.x"},{"key":"e_1_2_11_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.187"},{"key":"e_1_2_11_99_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1095"},{"key":"e_1_2_11_100_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.11832"},{"key":"e_1_2_11_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20527"},{"key":"e_1_2_11_102_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-065995"},{"key":"e_1_2_11_103_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03357"},{"key":"e_1_2_11_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22426"},{"key":"e_1_2_11_105_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117451"},{"key":"e_1_2_11_106_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.133"},{"key":"e_1_2_11_107_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.002"},{"key":"e_1_2_11_108_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.134"},{"key":"e_1_2_11_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00871.x"},{"key":"e_1_2_11_110_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-822968"},{"key":"e_1_2_11_111_2","first-page":"2997","article-title":"Tissue factor\/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism","volume":"63","author":"Hembrough TA","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_11_112_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.13.6922"},{"key":"e_1_2_11_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1098"},{"key":"e_1_2_11_114_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc865"},{"key":"e_1_2_11_115_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.5.16.3018"},{"key":"e_1_2_11_116_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00341.x"},{"key":"e_1_2_11_117_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH770>3.0.CO;2-Z"},{"key":"e_1_2_11_118_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.5.16.2985"},{"key":"e_1_2_11_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91569-T"},{"key":"e_1_2_11_120_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041590208"},{"key":"e_1_2_11_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(07)70126-3"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2008.01058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2008.01058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T05:30:43Z","timestamp":1693459843000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2008.01058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":120,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1600-0463.2008.01058.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2008.01058.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"2008-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}